Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis.

Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E, Chen L, Ouellet-Hellstrom R, Herrinton L, Liu L, Mitchel EF, Stein CM, Griffin MR
Arthritis Care Res (Hoboken). 2011 63 (10): 1415-24

PMID: 22121511 · PMCID: PMC3227007 · DOI:10.1002/acr.20550

MeSH Terms (23)

Adrenal Cortex Hormones Adult Aged Anti-Inflammatory Agents, Non-Steroidal Antirheumatic Agents Arthritis, Rheumatoid Cohort Studies Drug Administration Schedule Drug Therapy, Combination Female Humans Hydroxychloroquine Isoxazoles Leflunomide Male Methotrexate Middle Aged Narcotics Retrospective Studies Sulfasalazine Time Factors Treatment Outcome Tumor Necrosis Factor-alpha

Connections (3)

This publication is referenced by other Labnodes entities: